NPPNY.US Nippon Shinyaku Co Ltd ADR

Healthcare Pharmaceuticals USA Stocks
5.32 USD
Close of Nov 15, 2026
5.14 9.15
Market cap
USD 1.44B
P/E
7.0x
P/B
0.78x
ROE
10.7%
Dividend yield
3.67%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is NPPNY.US undervalued?

Graham number
Price5.32
Graham value10.83
Discount50.8%

NPPNY.US trades 50.8% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nippon Shinyaku Co Ltd ADR fundamental analysis

No fundamental analysis for Nippon Shinyaku Co Ltd ADR yet.

Nippon Shinyaku Co Ltd ADR stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nippon Shinyaku Co Ltd ADR

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with At…

Full company profile